AKT1 and myasthenia gravis: It is showed that AKT inhibitor could upregulate the number of Th1 and Th17 cells in peripheral blood of patients with myasthenia gravis, suggesting that AKT inhibitor could regulate the immune function of patients with myasthenia gravis (Feng and Qiu 2018).